DK1200070T3 - Ambroxolholdig sugetablet - Google Patents

Ambroxolholdig sugetablet

Info

Publication number
DK1200070T3
DK1200070T3 DK00949281T DK00949281T DK1200070T3 DK 1200070 T3 DK1200070 T3 DK 1200070T3 DK 00949281 T DK00949281 T DK 00949281T DK 00949281 T DK00949281 T DK 00949281T DK 1200070 T3 DK1200070 T3 DK 1200070T3
Authority
DK
Denmark
Prior art keywords
tablet
ambroxole
pressing
containing lozenge
amobroxol
Prior art date
Application number
DK00949281T
Other languages
Danish (da)
English (en)
Inventor
Frieder Maerz
Der Heydt Holger Hans-Herm Von
Horst Schmitt
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1200070(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1200070T3 publication Critical patent/DK1200070T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Fats And Perfumes (AREA)
DK00949281T 1999-07-20 2000-07-07 Ambroxolholdig sugetablet DK1200070T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette

Publications (1)

Publication Number Publication Date
DK1200070T3 true DK1200070T3 (da) 2003-10-06

Family

ID=7914872

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00949281T DK1200070T3 (da) 1999-07-20 2000-07-07 Ambroxolholdig sugetablet

Country Status (33)

Country Link
US (1) US6663889B1 (zh)
EP (2) EP1352646A3 (zh)
JP (1) JP3776041B2 (zh)
KR (1) KR100743846B1 (zh)
CN (1) CN1164263C (zh)
AT (1) ATE246493T1 (zh)
AU (1) AU776906B2 (zh)
BG (1) BG65503B1 (zh)
BR (1) BRPI0012553B8 (zh)
CA (1) CA2379314C (zh)
CZ (1) CZ301981B6 (zh)
DE (2) DE19933148A1 (zh)
DK (1) DK1200070T3 (zh)
EA (1) EA004044B1 (zh)
EE (1) EE04797B1 (zh)
ES (1) ES2173823T3 (zh)
HK (1) HK1045946B (zh)
HR (1) HRP20020050B1 (zh)
HU (1) HU229040B1 (zh)
IL (2) IL147261A0 (zh)
ME (1) MEP36808A (zh)
MX (1) MXPA02000546A (zh)
NO (1) NO331306B1 (zh)
NZ (1) NZ516987A (zh)
PL (1) PL197175B1 (zh)
PT (1) PT1200070E (zh)
RS (1) RS50246B (zh)
SI (1) SI1200070T1 (zh)
SK (1) SK284290B6 (zh)
TR (1) TR200200106T2 (zh)
UA (1) UA73313C2 (zh)
WO (1) WO2001005378A1 (zh)
ZA (1) ZA200200384B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
WO2012085185A1 (en) 2010-12-23 2012-06-28 Advance Holdings Limited Aqueous solution of ambroxol
JP6320931B2 (ja) 2011-12-22 2018-05-09 セントジーン アイピー ゲーエムベーハー リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ
CN109982692A (zh) 2016-11-14 2019-07-05 王明武 用于治疗眼表疾病的制剂和相关方法
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
DE3432411A1 (de) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach Antiadhaesive prohylactica und arzneimittel, enthaltend ein sekretolytisch wirksames benzylaminderivat
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
NZ516987A (en) 2003-08-29
PL352276A1 (en) 2003-08-11
BR0012553B1 (pt) 2014-05-27
PL197175B1 (pl) 2008-03-31
HRP20020050B1 (en) 2004-06-30
EE200200027A (et) 2003-04-15
KR100743846B1 (ko) 2007-08-02
EP1200070B1 (de) 2003-08-06
HRP20020050A2 (en) 2003-06-30
MEP36808A (en) 2011-02-10
BRPI0012553B8 (pt) 2021-05-25
JP3776041B2 (ja) 2006-05-17
HK1045946A1 (en) 2002-12-20
ES2173823T1 (es) 2002-11-01
CZ301981B6 (cs) 2010-08-25
EA004044B1 (ru) 2003-12-25
DE50003209D1 (de) 2003-09-11
CZ20014633A3 (cs) 2002-03-13
BR0012553A (pt) 2002-04-16
IL147261A0 (en) 2002-08-14
EA200200091A1 (ru) 2002-06-27
HU229040B1 (en) 2013-07-29
ES2173823T3 (es) 2004-04-16
EP1352646A2 (de) 2003-10-15
PT1200070E (pt) 2003-12-31
HK1045946B (zh) 2005-01-28
HUP0202021A3 (en) 2004-05-28
NO20020274L (no) 2002-03-13
AU776906B2 (en) 2004-09-23
CN1364075A (zh) 2002-08-14
SK812002A3 (en) 2002-06-04
EP1352646A3 (de) 2004-01-07
SK284290B6 (sk) 2005-01-03
CA2379314C (en) 2007-09-11
BG65503B1 (bg) 2008-10-31
CA2379314A1 (en) 2001-01-25
TR200200106T2 (tr) 2002-07-22
NO20020274D0 (no) 2002-01-18
NO331306B1 (no) 2011-11-21
ATE246493T1 (de) 2003-08-15
SI1200070T1 (en) 2003-12-31
EE04797B1 (et) 2007-04-16
ZA200200384B (en) 2002-10-30
DE19933148A1 (de) 2001-01-25
RS50246B (sr) 2009-07-15
CN1164263C (zh) 2004-09-01
US6663889B1 (en) 2003-12-16
MXPA02000546A (es) 2002-07-30
JP2003522125A (ja) 2003-07-22
BG106316A (en) 2002-08-30
AU6269900A (en) 2001-02-05
YU3802A (sh) 2004-09-03
WO2001005378A1 (de) 2001-01-25
HUP0202021A2 (hu) 2002-11-28
IL147261A (en) 2006-12-31
UA73313C2 (uk) 2005-07-15
EP1200070A1 (de) 2002-05-02
KR20020012316A (ko) 2002-02-15

Similar Documents

Publication Publication Date Title
DK1200070T3 (da) Ambroxolholdig sugetablet
WO1995017156A3 (en) Ethanol substitutes
DE69432789D1 (de) Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
AR021391A1 (es) Inhaladores presurizados de dosis medidas (mdi) y su uso.
EP1040827A3 (en) Use of 2-alkylpyrrolidines for the treatment of diabetes
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
IS2793B (is) Notkun á 3-hýdroxý-3-metýlglútarýl hjálparensíms A afsýringarkljúfshindrum til framleiðslunnar á lyfi til að meðhöndla sykursýkitaugakvilla
WO2005123043A3 (en) Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
ATE508725T1 (de) Verfahren zur herstellung von tabletten
DK0996653T3 (da) Phenolresin til limsammensætning, fremgangsmåde til fremstilling deraf og limsammensætning indeholdende den
WO2003051293A3 (en) Antidiabetic formulation and method
AU7525498A (en) Interactive system for substance presentation and elimination
DK1217999T3 (da) Anvendelse af baclofen til behandling af alkoholisme
WO2001083398A3 (de) System für die freisetzung von wirkstoffen
AR020833A1 (es) Articulo absorbente que comprende una pelicula microporosa ventilada
HRP20000781B1 (en) Effervescent preparations
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
WO2002057313A8 (en) Receptor-binding compounds and methods for identifying them
MX9602321A (es) Adhesivos de uretano de curado en humedad que contienen -butirolactona.
IT8719938A0 (it) Procedimento per la disidratazione di una miscela di metanolo e alcoli superiori.
ATE402719T1 (de) Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen
NO995032L (no) Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen
AU5848400A (en) Novel physiologically active substance, process for producing the same and use thereof